The metastatic cascade is reflected in the transcriptome of metastatic canine mammary carcinomas

Veterinary Journal

Volumn 190, Issue 2, 2011, Pages 236-243

  Klopfleisch, R ^a   Lenze, D ^b   Hummel, M ^b   Gruber, A D ^a  

^a FREIE UNIVERSITÄT BERLIN   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Breast cancer; Canine; Mammary tumor; Metastasis; Transcriptome

Indexed keywords

ANGIOPOIETIN 2; CD31 ANTIGEN; EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; MEMBRANE RECEPTOR; MUCIN 1; STAT5 PROTEIN; TIE 1 RECEPTOR; TISSUE INHIBITOR OF METALLOPROTEINASE 3; TRANSCRIPTOME;

ANGIOGENESIS; ANIMAL TISSUE; ARTICLE; BREAST CARCINOMA; CELL ADHESION; CELL CONTACT; CELL DEDIFFERENTIATION; CELL DIVISION; CELL PROLIFERATION; CONTROLLED STUDY; DOG DISEASE; DOWN REGULATION; EPITHELIUM; GENE CONTROL; GENE EXPRESSION; LYMPH NODE METASTASIS; MAMMARY GLAND; MOLECULAR PATHOLOGY; MULTIGENE FAMILY; NONHUMAN; TISSUE DIFFERENTIATION; UPREGULATION;

ANIMALS; BREAST NEOPLASMS; DOG DISEASES; DOGS; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LYMPHATIC METASTASIS; MAMMARY NEOPLASMS, ANIMAL; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RECEPTOR, ERBB-2; RECEPTORS, ESTROGEN; RNA, MESSENGER; TRANSCRIPTOME;

EID: 82855163900     PISSN: 10900233     EISSN: 15322971     Source Type: Journal    
DOI: 10.1016/j.tvjl.2010.10.018     Document Type: Article

References (31)

1. Bieche I., Nogues C., Lidereau R. Overexpression of BRCA2 gene in sporadic breast tumours. Oncogene 1999, 18:5232-5238.
2. Cardin S., Libby E., Pelletier P., Le Bouter S., Shiroshita-Takeshita A., Le Meur N., Leger J., Demolombe S., Ponton A., Glass L., Nattel S. Contrasting gene expression profiles in two canine models of atrial fibrillation. Circulation Research 2007, 100:425-433.
3. Cavalli L.R. Molecular markers of breast axillary lymph node metastasis. Expert Review of Molecular Diagnostics 2009, 9:441-454.
4. Gama A., Alves A., Gartner F., Schmitt F. p63: a novel myoepithelial cell marker in canine mammary tissues. Veterinary Pathology 2003, 40:412-420.
5. Honrado E., Osorio A., Palacios J., Benitez J. Pathology and gene expression of hereditary breast tumors associated with BRCA1, BRCA2 and CHEK2 gene mutations. Oncogene 2006, 25:5837-5845.
6. Hu Y., Hines L.M., Weng H., Zuo D., Rivera M., Richardson A., LaBaer J. Analysis of genomic and proteomic data using advanced literature mining. Journal of Proteome Research 2003, 2:405-412.
7. Huang da W., Sherman B.T., Lempicki R.A. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nature Protocols 2009, 4:44-57.
8. Klopfleisch R., Gruber A.D. Derlin-1 and stanniocalcin-1 are differentially regulated in metastasizing canine mammary adenocarcinomas. Journal of Comparative Pathology 2009, 141:113-120.
9. Klopfleisch R., Gruber A.D. Differential expression of cell cycle regulators p21, p27 and p53 in metastasizing canine mammary adenocarcinomas versus normal mammary glands. Research in Veterinary Science 2009, 87:91-96.
10. Klopfleisch R., Gruber A.D. Increased expression of BRCA2 and RAD51 in lymph node metastases of canine mammary adenocarcinomas. Veterinary Pathology 2009, 46:416-422.
11. Klopfleisch R., Schutze M., Gruber A.D. Downregulation of transforming growth factor beta (TGFbeta) and latent TGFbeta binding protein (LTBP)-4 expression in late stage canine mammary tumours. The Veterinary Journal 2009, 186:379-384.
12. Klopfleisch R., Klose P., Gruber A.D. The combined expression pattern of BMP2, LTBP4, and DERL1 discriminates malignant from benign canine mammary tumors. Veterinary Pathology 2010, 47:446-454.
13. Klopfleisch R., Schutze M., Gruber A.D. RAD51 protein expression is increased in canine mammary carcinomas. Veterinary Pathology 2010, 47:98-101.
14. Klopfleisch R., Hvid H., Klose P., Da Costa A., Gruber AD. Insulin receptor is expressed in normal canine mammary gland and benign adenomas but ecreased in metastatic canine mammary carcinomas similar to human breastcancer. Veterinary and Comparative Oncology 2010, 8:293-301.
15. Klopfleisch R., Klose P., da Costa A., Brunnberg L., Gruber A.D. HEPACAM1 and 2 are differentially regulated in canine mammary adenomas and carcinomas and its lymph node metastases. BMC Veterinary Research 2010, 6:15.
16. Klopfleisch R., Schutze M., Gruber A.D. Loss of p27 expression in canine mammary tumors and their metastases. Research in Veterinary Science 2010, 88:300-303.
17. Klopfleisch R., Schutze M., Linzmann H., Brunnberg L., Gruber A.D. Increased Derlin-1 expression in metastases of canine mammary adenocarcinomas. Journal of Comparative Pathology 2010, 142:79-83.
18. Klopfleisch R., Klose P., Weise C., Bondzio A., Multhaup G., Einspanier R., Gruber A.D. The proteome of metastatic canine mammary carcinomas: similarities and differences to human breast cancer. Journal of Proteome Research 2010, PMID: 20932060.
19. Krol M., Polanska J., Pawlowski K.M., Turowski P., Skierski J., Majewska A., Ugorski M., Morty R.E., Motyl T. Transcriptomic signature of cell lines isolated from canine mammary adenocarcinoma metastases to lungs. Journal of Applied Genetics 2009, 51:37-50.
20. Maacke H., Opitz S., Jost K., Hamdorf W., Henning W., Kruger S., Feller A.C., Lopens A., Diedrich K., Schwinger E., Sturzbecher H.W. Over-expression of wild-type Rad51 correlates with histological grading of invasive ductal breast cancer. International Journal of Cancer 2000, 88:907-913.
21. Misdorp W., Hart A.A. Canine mammary cancer. II. Therapy and causes of death. Journal of Small Animal Practice 1979, 20:395-404.
22. Misdorp W., Else R.W., Hellmén E., Lipscomb T.P. Histological Classification of Mammary Tumors of the Dog and the Cat 1999, vol. 7. Armed Forces Institute of Pathology, Washington.
23. Nieto A., Perez-Alenza M.D., Del Castillo N., Tabanera E., Castano M., Pena L. BRCA1 expression in canine mammary dysplasias and tumours: relationship with prognostic variables. Journal of Comparative Pathology 2003, 128:260-268.
24. Rao N.A., van Wolferen M.E., Gracanin A., Bhatti S.F., Krol M., Holstege F.C., Mol J.A. Gene expression profiles of progestin-induced canine mammary hyperplasia and spontaneous mammary tumors. Journal of Physiology and Pharmacology Suppl. 1 2009, 60:73-84.
25. Salomonis N., Hanspers K., Zambon A.C., Vranizan K., Lawlor S.C., Dahlquist K.D., Doniger S.W., Stuart J., Conklin B.R., Pico A.R. GenMAPP 2: new features and resources for pathway analysis. BiomedCentral Bioinformatics 2007, 8:217.
26. Thomassen M., Tan Q., Kruse T.A. Gene expression meta-analysis identifies metastatic pathways and transcription factors in breast cancer. BiomedCentral Cancer 2008, 8:394.
27. Thompson M.E., Jensen R.A., Obermiller P.S., Page D.L., Holt J.T. Decreased expression of BRCA1 accelerates growth and is often present during sporadic breast cancer progression. Nature Genetics 1995, 9:444-450.
28. Uva P., Aurisicchio L., Watters J., Loboda A., Kulkarni A., Castle J., Palombo F., Viti V., Mesiti G., Zappulli V., Marconato L., Abramo F., Ciliberto G., Lahm A., La Monica N., de Rinaldis E. Comparative expression pathway analysis of human and canine mammary tumors. BiomedCentral Genomics 2009, 10:135.
29. van't Veer L.J., Dai H., van de Vijver M.J., He Y.D., Hart A.A., Mao M., Peterse H.L., van der Kooy K., Marton M.J., Witteveen A.T., Schreiber G.J., Kerkhoven R.M., Roberts C., Linsley P.S., Bernards R., Friend S.H. Gene expression profiling predicts clinical outcome of breast cancer. Nature 2002, 415:530-536.
30. Wakefield L.M., Yang Y.A., Dukhanina O. Transforming growth factor-beta and breast cancer: lessons learned from genetically altered mouse models. Breast Cancer Research 2000, 2:100-106.
31. Weigelt B., Peterse J.L., van 't Veer L.J. Breast cancer metastasis: markers and models. Nature Reviews Cancer 2005, 5:591-602.